Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-16 Purchase |
2022-06-21 10:02 am |
Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC See Remarks 10% Owner |
1,200,000 | $8.25 | $9,900,000 | 2,826,389 (Indirect) |
View |
| 2021-04-26 Sale |
2021-04-28 8:30 pm |
Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer |
17,813 | $8.86 | $157,823 | 3,841 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-07 Option Award |
2023-06-08 4:37 pm |
N/A 2033-06-07 |
Cogent Biosciences Inc. | COGT | Harwin Peter Evan Director |
36,700 | $0 | 36,700 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-04 4:16 pm |
2023-04-03 2033-04-03 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
2,053 | $0 | 2,053 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-04 4:15 pm |
2023-04-03 2033-04-03 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
1,900 | $0 | 1,900 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 3:52 pm |
N/A 2033-02-13 |
Cogent Biosciences Inc. | COGT | Robinson John Edward Chief Scientific Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 3:51 pm |
N/A 2033-02-13 |
Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 3:50 pm |
N/A 2033-02-13 |
Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 3:50 pm |
N/A 2033-02-13 |
Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 3:49 pm |
N/A 2033-02-13 |
Cogent Biosciences Inc. | COGT | Robbins Andrew R President and CEO |
525,000 | $0 | 525,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:31 pm |
2023-01-03 2033-01-03 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
1,792 | $7.1854 | 1,792 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:30 pm |
2023-01-03 2033-01-03 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
1,862 | $7.1854 | 1,862 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-04 4:35 pm |
2022-10-03 2032-10-03 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
1,419 | $9.076 | 1,419 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-04 4:30 pm |
2022-10-03 2032-10-03 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
1,474 | $9.076 | 1,474 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-05 1:52 pm |
2022-07-01 2032-07-01 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
2,279 | $5.8706 | 2,279 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-05 1:51 pm |
2022-07-01 2032-07-01 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
2,194 | $5.8706 | 2,194 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-01 09:19 am |
N/A N/A |
Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer |
622 | $7.395 | 622 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:13 pm |
N/A 2032-06-07 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
30,700 | $0 | 30,700 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:10 pm |
N/A 2032-06-07 |
Cogent Biosciences Inc. | COGT | Morris Arlene Director |
30,700 | $0 | 30,700 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:09 pm |
N/A 2032-06-07 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
30,700 | $0 | 30,700 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:09 pm |
N/A 2032-06-07 |
Cogent Biosciences Inc. | COGT | CAIN CHRISTOPHER W. Director |
30,700 | $0 | 30,700 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:08 pm |
N/A 2032-06-07 |
Cogent Biosciences Inc. | COGT | Harwin Peter Evan Director |
30,700 | $0 | 30,700 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:07 pm |
N/A 2032-06-07 |
Cogent Biosciences Inc. | COGT | Shegog Todd Director |
30,700 | $0 | 30,700 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:06 pm |
2022-04-01 2032-04-01 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
2,753 | $4.86 | 2,753 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:05 pm |
2022-04-01 2032-04-01 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
2,650 | $4.86 | 2,650 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 5:47 pm |
N/A 2032-01-25 |
Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer |
225,000 | $4.9432 | 225,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 5:46 pm |
N/A 2032-01-25 |
Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer |
250,000 | $4.9432 | 250,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 5:42 pm |
N/A 2032-01-25 |
Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer |
202,250 | $4.9432 | 202,250 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 5:40 pm |
N/A 2032-01-25 |
Cogent Biosciences Inc. | COGT | Robinson John Edward Chief Scientific Officer |
250,000 | $4.9432 | 250,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 5:37 pm |
N/A 2032-01-25 |
Cogent Biosciences Inc. | COGT | Robbins Andrew R President and CEO |
690,000 | $4.9432 | 690,000 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 9:25 pm |
N/A N/A |
Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer |
674 | $6.817 | 674 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 9:25 pm |
N/A 2032-01-03 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
2,329 | $5.153 | 2,329 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 9:24 pm |
N/A 2032-01-03 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
2,256 | $5.153 | 2,256 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 7:45 pm |
N/A 2031-10-01 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
2,385 | $5.0317 | 2,385 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 7:11 pm |
N/A 2031-10-01 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
2,463 | $5.0317 | 2,463 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 7:08 pm |
N/A 2031-07-01 |
Cogent Biosciences Inc. | COGT | Ros Matthew Director |
2,225 | $4.7754 | 2,225 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 7:05 pm |
N/A 2031-07-01 |
Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director |
2,513 | $4.7754 | 2,513 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 4:37 pm |
N/A 2031-05-03 |
Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer |
260,000 | $0 | 260,000 (Direct) |
View |
Ownership |
2021-04-15 07:57 am |
N/A 2031-03-31 |
Cogent Biosciences Inc. | COGT | Robinson John Edward Chief Scientific Officer |
0 | $0 | 500,000 (Direct) |
View |